Product Information
Enavatuzumab, a humanized IgG1 mAb, targets TWEAK receptor, inhibiting tumor growth via TweakR signaling and ADCC.
Chemical properties
Technical inquiry about: TM-T76865 Enavatuzumab
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.